Spotlight: How SPACs Can Fight Cancer
Welcome to SPACInsider’s first Spotlight feature! In this series we will seek to illuminate a particular trend in SPACs that deserves a greater focus. This week, we will be looking at Chamath Palihapitya’s second biotech SPAC, Social Capital Suvretta II (NYSE:DNAB) and the oncology market, with research compiled by SPACInsider contributor Anthony Sozzi. ...READ MORE
Spartan Acquisition Corp. II (SPRQ) Shareholders Approve Sunlight Financial Deal
Spartan II (NYSE:SPRQ) shareholders have approved the company’s combination with residential solar financier Sunlight Financial at a special meeting earlier today.
The initial press release did not disclose redemption figures, and Spartan II was in the danger zone with its shares trading at or below $10 nearly without pause since April. ...READ MORE
